[HTML][HTML] Dual antiplatelet or dual antithrombotic therapy for secondary prevention in high-risk patients with stable coronary artery disease?

W Sumaya, T Geisler, SD Kristensen… - Thrombosis and …, 2019 - thieme-connect.com
… for stroke prevention in AF) in addition to DAPT (aspirin + clopidogrel) resulted in increased
risk of … intracranial and fatal bleeds, without a clear benefit of ischaemic risk reduction.[28] …

[HTML][HTML] Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?

JGF Cleland - Thrombosis and Haemostasis, 2022 - thieme-connect.com
… at higher risk of both cardiovascular disease and cancer, the balance of risk and benefit of
primary prevention for aspirin … function but clopidogrel has only marginally greater effects on …

Aspirin use for primary prevention of cardiovascular disease in older patients: a review of clinical guidelines and updated evidence

J Lewis, L Bethishou, LV Tsu - The Senior Care Pharmacist, 2019 - ingentaconnect.com
prevention studies completed between 1988 and 2005.This study found that aspirin reduced
the composite of serious vascular events … (composite of CV events) and an increased risk of …

[HTML][HTML] Clopidogrel plus aspirin use is associated with worse long-term outcomes, but aspirin use alone is safe in patients with vasospastic angina: results from the …

SS Cho, SH Jo, SH Han, KY Lee, SH Her, MH Lee… - Scientific reports, 2019 - nature.com
… of aspirin plus clopidogrel to be an independent risk factor … , sex, history of coronary heart
disease (CHD, CHD was defined … To avoid the potential bias of selecting patients at high risk in …

An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2024 - Am Heart Assoc
… after PCI without increasing cardiovascular events, but its efficacy … clopidogrel was associated
with no signal of harm in terms of … patients at high risk for bleeding within 1 month after PCI. …

Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events

A Bálint, D Tornyos, O El Alaoui El Abdallaoui, P Kupó… - Stroke, 2021 - Am Heart Assoc
patients with high risk for cardiovascular or cerebrovascular disease, defined as coronary
artery disease… % lower with aspirin plus clopidogrel and 20% lower with aspirin plus ticagrelor (…

P2Y12 inhibitors versus aspirin monotherapy for long-term secondary prevention of atherosclerotic cardiovascular disease events: a systematic review and meta …

A Al-Abdouh, W Abusnina, M Mhanna… - … problems in cardiology, 2022 - Elsevier
… The HOST-EXAM 6 (Aspirin vs clopidogrel for chronic … the risk of myocardial infarction
and stroke among patients using … for patients with acute myocardial infarction and high risk

… of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the …

H Watanabe, T Morimoto, M Natsuaki… - … cardiology, 2022 - jamanetwork.com
… PCI, patients in the 1- to 2-month DAPT group were to stop … DAPT with aspirin and clopidogrel.
Others might argue that … for the numerically higher rate of cardiovascular events in the 1- …

Antithrombotic therapy for atherosclerotic cardiovascular disease risk mitigation in patients with coronary artery disease and diabetes mellitus

D Capodanno, DJ Angiolillo - Circulation, 2020 - Am Heart Assoc
… The higher risk of atherosclerotic cardiovascular disease (… by aspirin because of the presence
of vascular disease impairing … patients with DM treated with clopidogrel, 21 vascular events

[HTML][HTML] Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the …

S Uchiyama, S Goto, H Origasa, N Uemura, K Sugano… - Heart and Vessels, 2020 - Springer
… , our results suggested that aspirin is not recommended for the prevention of CV events in …
Our registry recruited patients receiving low-dose aspirin who were at high risk of CV events in …